"10.1371_journal.pone.0130700","plos one","2015-06-24T00:00:00Z","Bin Li; Hyunjin Shin; Georgy Gulbekyan; Olga Pustovalova; Yuri Nikolsky; Andrew Hope; Marina Bessarabova; Matthew Schu; Elona Kolpakova-Hart; David Merberg; Andrew Dorner; William L Trepicchio","Department of Translational Medicine, Takeda Pharmaceuticals International Co., 35 Landsdowne St., Cambridge, Massachusetts, 02139, United States of America; Thomson Reuters, 777 E. Eisenhower Parkway, Ann Arbor, Michigan, 48108, United States of America","Conceived and designed the experiments: BL WLT. Performed the experiments: BL HS GG OP YN AH MB MS EK DM AD WLT. Analyzed the data: BL HS GG OP. Wrote the paper: BL OP WLT.","Co-authors Bin Li, Hyunjin Shin, Matthew Schu, David Merberg, Andrew Dorner, and William L. Trepicchio are employed by Takeda Pharmaceuticals International Co. Co-authors Georgy Gulbekyan, Olga Pustovalova, Yuri Nikolsky, Andrew Hope, Marina Bessarabova, and Elona Kolpakova-Hart are employed by Thomson Reuters. The authors applied a patent: Bin Li, Hyunjin Shin, Stephen J. Blakemore, and William L. Trepicchio, BIOMARKERS AND METHODS TO PREDICT RESPONSE TO INHIBITORS AND USES THEREOF, US Provisional Patent Application No. 61/708,349, 2012. PCT Application No. PCT/US13/62902. There are no products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","06","Bin Li","BL",12,TRUE,2,12,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
